NCT05883345Completed
Blood Tests for Gastritis and Gastric Neoplasms
Validation of Blood Test Finding for the Diagnosis of Gastritis and Gastric Neoplasms
Source: ClinicalTrials.gov · Last updated 11 Mar 2025
Brief summary (registry, in English)
Helicobacter pylori infection rate is decreasing in younger population; however, biennial gastroscopy is still recommended for all Koreans aged between 40 and 75 years. This study aimed to validate blood tests for gastric cancer screening according to the infection status of H. pylori (naive, current, and past infection).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1490 (actual)
- First submitted
- 9 May 2023
- Start date
- 1 May 2023
- Primary completion date
- 30 Aug 2024
- Lead sponsor
- Konkuk University Medical Center
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05883345
What you commit to
- Study type: Observational
- Participants enrolled: 1490
- From 1 May 2023 to the primary completion date, 30 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of gastrectomy
- Renal insufficiency
Other
- Severe comorbidities requiring prompt management
Who the study is looking for
- Individuals who visited for gastric cancer screening
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Konkuk University Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.